Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis in systemic lupus erythematosus

C Drenkard1, A R Villa, E Reyes

  • 1Department of Immunology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico.

Lupus
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationships among organ damage, social support, and depression in African American women with systemic lupus erythematosus.

Lupus·2018
Same author

Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus.

Lupus·2017
Same author

Are there "Attenuated" Forms of Evans Syndrome?

Hematology (Amsterdam, Netherlands)·2016
Same author

Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.

Lupus·2016
Same author

Proposal and validation of a clinical trunk control test in individuals with spinal cord injury.

Spinal cord·2014
Same author

Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.

Arthritis care & research·2013

This study investigated vasculitis in systemic lupus erythematosus (SLE) patients, finding it affects nearly 40% over 10 years. Vasculitis, especially visceral, is linked to worse outcomes and other lupus manifestations.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
  • Vasculitis, inflammation of blood vessels, is a known but incompletely understood complication of SLE.
  • Understanding the epidemiology and clinical impact of vasculitis in SLE is crucial for patient management.

Purpose of the Study:

  • To determine the frequency, location, and clinical features of vasculitis in a large cohort of SLE patients.
  • To identify associated clinical and histopathological manifestations and prognostic factors.
  • To explore the relationship between vasculitis and other SLE manifestations, including antiphospholipid syndrome.

Main Methods:

  • Retrospective analysis of 667 SLE patients, with 540 included after exclusions.

Related Experiment Videos

  • Assessment of vasculitis incidence density, cumulative incidence, and types (cutaneous, visceral, or both).
  • Clinical and histopathological data collection, including biopsy and arteriography for confirmation.

    • Main Results:

    • The cumulative incidence of vasculitis in SLE patients reached 41.1% at 10 years.
    • Cutaneous vasculitis (160 patients) was more common than visceral vasculitis (24 patients).
    • Visceral vasculitis was associated with increased mortality, particularly when controlled for age of onset and nephropathy.

    Conclusions:

    • Vasculitis is a significant complication in SLE, impacting disease course and prognosis.
    • Specific SLE manifestations like myocarditis, psychosis, and antiphospholipid syndrome are associated with vasculitis.
    • Visceral vasculitis in SLE patients portends a poorer prognosis, highlighting the need for vigilant monitoring and management.